Dr. Julie Rani Nangia, Assistant Professor of Medicine is a breast medical oncologist and the medical director of the Lester & Sue Smith Breast Center, Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine in Houston, TX. She is board certified in internal medicine and medical oncology. Dr. Nangia received her medical degree from the University of Missouri-Kansas City, completed an internal medicine residency at The University of Texas Health Science Center in Houston and a hematology-oncology fellowship at Rush University Medical Center in Chicago, IL. Dr. Nangia specializes in the care of patients with breast cancer or at high risk to develop breast cancer. She is the Director of the Breast Cancer Prevention and High Risk Program at Baylor College of Medicine and has a special interest in hereditary breast cancer, breast cancer prevention and triple negative breast cancer. Her research interests are in breast cancer prevention, metastatic triple negative breast cancer, understanding mechanisms of metastatic breast cancer and prevention of chemotherapy-induced alopecia. She is the principal investigator of many institutional, national and global trials and is currently the national PI on 2 multi-site investigator initiated clinical trials. She is international most well known for her research with scalp cooling for the prevention of chemotherapy-induced alopecia and was the national PI for the SCALP trial which is the only randomized clinical trial with scalp cooling devices in the world and led to FDA clearance of a scalp cooling device in the US.